(Q41644493)

6 October 2017

Evidence for a non-estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivo (English)

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

12 November 2022

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

12 November 2022

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

12 November 2022

author name string

Hartley-Asp B

5

1 reference

6 October 2017

S. Eklöv

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1736276

12 November 2022

S. Nilsson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1736276

12 November 2022

A. Larson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1736276

12 November 2022

P. Björk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1736276

12 November 2022

B. Hartley-Asp

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1736276

12 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1736276

12 November 2022

publication date

1 January 1992

1 reference

full work available at URL

6 October 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.2990200106

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

https://onlinelibrary.wiley.com/doi/full/10.1002/pros.2990200106

12 November 2022

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

12 November 2022

1 reference

6 October 2017

20

1 reference

6 October 2017

1

1 reference

6 October 2017

43-50

1 reference

Isolation of a human prostate carcinoma cell line (DU 145)

6 October 2017

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/IJC.2910210305

Estramustine phosphate therapy in carcinoma of the prostate

1

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Treatment of Advanced Prostatic Carcinoma with Estramustine Phosphate (Estracyt®)

12 November 2022

2

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Extended Therapy of Stage D Carcinoma of the Prostate with Oral Estramustine Phosphate

12 November 2022

3

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Treatment of advanced carcinoma of the prostate with estramustine phosphate

12 November 2022

4

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Estramustine phosphate compared with diethylstilbestrol. A randomized, double-blind, crossover trial for stage D prostate cancer

12 November 2022

5

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

12 November 2022

Acta urologica Belgica

6

48

133

Nilsson

1980

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Progress in Clinical and Biological Research

12 November 2022

7

243B

221

Murphy

1987

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma

12 November 2022

8

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Plasma Concentrations of Estramustine Phosphate and Its Major Metabolites in Patients with Prostatic Carcinoma Treated with Different Doses of Estramustine Phosphate (Estracyt®)

12 November 2022

9

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3

12 November 2022

10

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Effect of estramustine phosphate on the assembly of trypsin-treated microtubules and microtubules reconstituted from purified tubulin with either tau, MAP2, or the tubulin-binding fragment of MAP2

12 November 2022

14

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Pilot Study on the Growth Inhibition by Estramustine Phosphate (Estracyt®) of Rat Mammary Tumours Sensitive and Insensitive to Oestrogen

12 November 2022

16

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Approaches to prostatic cancer chemotherapy using the Dunning R3327H prostatic adenocarcinoma

12 November 2022

17

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Growth and cell survival following treatment with estramustine nor-nitrogen mustard, estradiol and testosterone of a human prostatic cancer cell line (DU 145)

12 November 2022

18

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer

12 November 2022

22

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of estradiol-17 beta

12 November 2022

23

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

Proceedings of the American Association for Cancer Research

12 November 2022

24

32

Seidman

1991

1 reference

https://api.crossref.org/works/10.1002/PROS.2990200106

12 November 2022

Identifiers

1 reference

6 October 2017

1 reference